spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online April 20, 2007
Journal of Experimental Biology 210, 1518-1525 (2007)
Published by The Company of Biologists 2007
doi: 10.1242/jeb.001370
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Glossary
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JEB
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, N.

Advanced sequencing technologies and their wider impact in microbiology

Neil Hall

School of Biological Sciences, Biosciences Building, Crown Street, University of Liverpool, Liverpool L69 7ZB, UK


Figure 1
View larger version (26K):
[in this window]
[in a new window]

 
Fig. 1. An overview of current and emerging technologies for genomic sequencing. Sequencing can be classified into four main strategies: in vitro cloning, in vivo cloning, amplification and mass spectrometry, and single-molecule approaches. The mass spectrometry and single-molecule approaches are still either very specialized or in the developmental stages, although mass spectrometry methods such as the MassArray method is commonly used for single nucleotide polymorphism (SNP) analysis (Jurinke et al., 2002Go). In vivo cloning followed by Sanger sequencing is the workhorse method of most current genome sequencing projects. The in vitro cloning technologies can be further divided into methods that employ sequencing by synthesis, such as the 454 and Solexa methods, or those that use hybridization and ligation of oligonucleotides, such as MPSS (massively parallel signature sequencing) and polony methods.

 

Figure 2
View larger version (41K):
[in this window]
[in a new window]

 
Fig. 2 Outline of the 454 and polony sequencing process. Both systems first fragment the genomic DNA (Step 1) and then use a process of in vitro cloning followed by amplification. The 454 process is shown on the left and Polony sequencing is shown on the right. In the 454 protocol, the linkers are ligated onto the ends of the DNA (Step 2a). Polony sequencing involves circularization followed by linearization and the addition of linkers to generate two fragments with a spacer between them and linkers at the end (Step 2B). Both processes then attach the in vitro clones to beads and carry out PCR in an emulsion mixture to generate beads with many clonal copies of the target fragments (Step 3a/3b). For the sequencing step, the beads must be immobilized in a single layer to allow imaging in an environment that enables the reaction reagents to be flowed across them. In the case of 454 sequencing, a picotiter plate is used, in which most cells will contain a single bead (Step 4a). The polony method immobilizes the beads in an acrylamide matrix in a dense monolayer (Step 4b). The methods are very similar up until the point of the sequencing reaction; in the case of 454 sequencing, a DNA synthesis reaction from a single sequencing primer is carried out. Bases are flowed across the picotiter plate one at a time and incorporation is detected by the release of light (Step 5a). The polony method uses ligation to anchor primers, which can be annealed in one of four positions. In each cycle, a population of degenerate nonomers, which have been fluorescently labeled, is added to the monolayer, and only complimentary oligos will anneal and ligate to the anchor primer.

 





© The Company of Biologists Ltd 2007